SYRE
NASDAQStockSpyre Therapeutics, Inc.
$40.41-1.13 (-2.71%)
52-Week Range
$11.80
$44.18
Key Stats
Market Cap
2.4B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
3.12
Volume
463.8K
Avg Volume
830.7K
Performance
1M
+23.66%
3M
+23.44%
6M
+179.65%
YTD
+35.71%
1Y
+119.81%
3Y
+163.99%
5Y
+163.99%
Price Chart
ETF Exposure
SYRE is held by 76 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About SYRE ETF Exposure
Spyre Therapeutics, Inc. (SYRE) is held by 76 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, SYRE is a widely held institutional stock. The stock currently trades at $40.41. Investors can gain exposure to SYRE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SYRE, sorted by portfolio weight.